Involvement of PACAP/ADNP signaling in the resistance to cell death in malignant peripheral nerve sheath tumor (MPNST) cells.
about
Mesenchymal stem cells-based therapy as a potential treatment in neurodegenerative disorders: is the escape from senescence an answer?PACAP interacts with PAC1 receptors to induce tissue plasminogen activator (tPA) expression and activity in schwann cell-like culturesAmeliorative effects of PACAP against cartilage degeneration. Morphological, immunohistochemical and biochemical evidence from in vivo and in vitro models of rat osteoarthritis.Emerging Role of PACAP as a New Potential Therapeutic Target in Major Diabetes Complications.PACAP and VIP Inhibit the Invasiveness of Glioblastoma Cells Exposed to Hypoxia through the Regulation of HIFs and EGFR ExpressionVIP Family Members Prevent Outer Blood Retinal Barrier Damage in a Model of Diabetic Macular Edema.Characterization of matrix metalloproteinase-2 and -9, ADAM-10 and N-cadherin expression in human glioblastoma multiforme.Mucin 1 (MUC1) signalling contributes to increase the resistance to cell death in human bronchial epithelial cells exposed to nickel acetate.NAP reduces murine microvascular endothelial cells proliferation induced by hyperglycemia.Antiproliferative effects of PACAP and VIP in serum-starved glioma cells.Nap Interferes with Hypoxia-Inducible Factors and VEGF Expression in Retina of Diabetic Rats.PACAP Modulates Expression of Hypoxia-Inducible Factors in Streptozotocin-Induced Diabetic Rat Retina.Alterations in Activity-Dependent Neuroprotective Protein in Sporadic and Experimental Parkinson's Disease.NAP counteracts hyperglycemia/hypoxia induced retinal pigment epithelial barrier breakdown through modulation of HIFs and VEGF expression.Identification of Dysregulated microRNA Networks in Schwann Cell-Like Cultures Exposed to Immune Challenge: Potential Crosstalk with the Protective VIP/PACAP Neuropeptide System.
P2860
Q26801122-0E35FABD-BAD2-4079-AF1E-24A2C5409C48Q28543252-49E2EBAA-4E25-4ACC-BFD5-033A6D2DBE64Q35381453-02078452-B5E3-4712-A449-52EF29BB87D4Q35657065-219A04C6-C0B6-4CA0-956D-469AB9423772Q36948641-25FACB44-1ABB-44ED-BE2A-78BAEE1D3949Q38754080-814FF7BE-83CF-41BC-BE17-3A8970E1E527Q38878322-4C35CC05-9514-4E03-B1B0-61FFCBFB9D2DQ38972631-B01D46E0-5155-4A0B-8CB1-C7EFBA535F80Q38990446-32588402-4628-40E3-A5FB-193FCECCBC69Q39117664-9539F57B-0279-4833-ABF7-EA084DEE6AC8Q39137563-B6544F17-6383-4405-8CF2-58F6DAC54158Q40706346-77EABBFA-5DE1-44B0-8A15-D79C8C2C803DQ40838916-E93F0595-CFB7-4BF8-BD71-BEF2A5EC5F36Q47911906-D9636833-5743-4A20-8BB1-AFEA35A0A9B9Q51731153-7FB46D67-BB4A-49EE-8D45-D5DB9951F467
P2860
Involvement of PACAP/ADNP signaling in the resistance to cell death in malignant peripheral nerve sheath tumor (MPNST) cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Involvement of PACAP/ADNP sign ...... ve sheath tumor (MPNST) cells.
@en
Involvement of PACAP/ADNP sign ...... peripheral nerve sheath tumor
@nl
type
label
Involvement of PACAP/ADNP sign ...... ve sheath tumor (MPNST) cells.
@en
Involvement of PACAP/ADNP sign ...... peripheral nerve sheath tumor
@nl
prefLabel
Involvement of PACAP/ADNP sign ...... ve sheath tumor (MPNST) cells.
@en
Involvement of PACAP/ADNP sign ...... peripheral nerve sheath tumor
@nl
P2860
P50
P1476
Involvement of PACAP/ADNP sign ...... rve sheath tumor (MPNST) cells
@en
P2093
Soraya Scuderi
P2860
P2888
P304
P356
10.1007/S12031-012-9755-Z
P577
2012-03-28T00:00:00Z